Winthrop Capital Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Winthrop Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$203K	Hold	6,000	–	–	0.05%	121
2026 Q1	$181K	Hold	6,000	–	–	0.05%	125
2025 Q4	$187K	Hold	6,000	–	–	0.04%	131
2025 Q3	$121K	Hold	6,000	–	–	0.03%	137
2025 Q2	$101K	Hold	6,000	–	–	0.03%	152
2025 Q1	$92K	Hold	6,000	–	–	0.03%	141
2024 Q4	$134K	Hold	6,000	–	–	0.04%	137
2024 Q3	$108K	Buy	+6,000	New	+$105K	0.05%	71

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Winthrop Capital Management's TEVA Position: Q2 2026 in Review

Winthrop Capital Management held its Teva Pharmaceutical Industries Limited (TEVA) position steady in Q2 2026 at 6,000 shares worth $203K. The position accounts for 0.05% of the portfolio, ranked #121.

Winthrop Capital Management first reported a position in TEVA in Q3 2024 and has held it in 8 quarters since. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Winthrop Capital Management held 6,000 shares of Teva Pharmaceutical Industries Limited worth $203K as of Q2 2026.
Winthrop Capital Management left its Teva Pharmaceutical Industries Limited share count unchanged in Q2 2026.
Teva Pharmaceutical Industries Limited made up 0.05% of Winthrop Capital Management's portfolio in Q2 2026, its #121 holding.
Winthrop Capital Management first reported a position in Teva Pharmaceutical Industries Limited in Q3 2024 and has held it in 8 quarters since.
676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Winthrop Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.